REVIEW ARTICLE
Chronic cough - different diagnostic models.
Diagnostics according to the anatomical protocol versus early diagnosis of refractory chronic cough.
More details
Hide details
1
Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Polska
Submission date: 2026-06-03
Final revision date: 2026-08-07
Acceptance date: 2026-08-20
Publication date: 2026-09-29
Corresponding author
Katarzyna Anna Białek-Gosk
Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Banacha 1A, 02-097, Warsaw, Polska
RhinoScope 2026;1(3):1-8
KEYWORDS
TOPICS
ABSTRACT
Chronic cough is one of the most common reasons for seeking medical consultation. Evaluation of its underlying cause generally includes chest radiography, spirometry, and selected laboratory tests. Despite an accurate diagnosis and appropriate treatment, satisfactory improvement is not achieved in some patients. Refractory chronic cough represents an important clinical challenge: it impairs quality of life, is associated with a higher burden of anxiety and depressive symptoms, and increases healthcare costs. Early recognition of refractory chronic cough may reduce unnecessary diagnostic testing and enable earlier initiation of neuromodulatory or non-pharmacological treatment. This review describes the evolution of diagnostic approaches to chronic cough, from traditional anatomy-based protocols to the contemporary concept of cough reflex hypersensitivity, which facilitates earlier recognition of refractory chronic cough. Delayed diagnosis and treatment may be associated with a greater burden of anxiety and depressive symptoms and higher healthcare costs. Chronic cough related to cough reflex hypersensitivity may be considered a neuropathic disorder requiring a distinct diagnostic and therapeutic approach. CANVAS syndrome (cerebellar ataxia, neuropathy and vestibular areflexia syndrome) is an example of a neuropathic condition in which cough may result from neuronal dysfunction.
REFERENCES (24)
1.
Irwin RS, Baumann MH, Bolser DC, Boulet LP, Braman SS, Brightling CE, et al. Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(Suppl 1):1S–23S. doi:10.1378/chest.129.1_suppl.1S.
2.
Morice AH, McGarvey L, Pavord I. Recommendations for the management of cough in adults. Thorax. 2006;61(Suppl 1):i1–i24. doi:10.1136/thx.2006.065144.
3.
Morice AH, Fontana GA, Sovijarvi ARA, Pistolesi M, Chung KF, Widdicombe J, et al. The diagnosis and management of chronic cough. Eur Respir J. 2004;24(3):481–492. doi:10.1183/09031936.04.00027804.
4.
Irwin RS, French CL, Chang AB, Altman KW, CHEST Expert Cough Panel. Classification of cough as a symptom in adults and management algorithms: CHEST guideline and expert panel report. Chest. 2018;153(1):196–209. doi:10.1016/j.chest.2017.10.016.
5.
Gibson P, Wang G, McGarvey L, Vertigan AE, Altman KW, Birring SS. Treatment of unexplained chronic cough: CHEST guideline and expert panel report. Chest. 2016;149(1):27–44. doi:10.1378/chest.15-1496.
6.
Morice AH, Millqvist E, Bieksiene K, Birring SS, Dicpinigaitis P, Domingo Ribas C, et al. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J. 2020;55(1):1901136. doi:10.1183/13993003.01136-2019.
7.
Parker SM, Smith JA, Birring SS, Chamberlain-Mitchell S, Gruffydd-Jones K, Haines J, et al. British Thoracic Society Clinical Statement on chronic cough in adults. Thorax. 2023;78(Suppl 6):3–19. doi:10.1136/thorax-2023-220592.
8.
Guilleminault L, Demoulin-Alexikova S, de Gabory L, Bruley des Varannes S, Brouquières D, Balaguer M, et al. Recommandations de prise en charge de la toux chronique de l’adulte. Guidelines for the management of chronic cough in adults. Rev Mal Respir. 2023;50(5):432–452. doi:10.1016/j.rmr.2023.03.001.
9.
Birring SS, Spinou A. How best to measure cough clinically. Curr Opin Pharmacol. 2015;22:37–40. doi:10.1016/j.coph.2015.03.003.
10.
Hassan W, Mayhew AJ, Sohel N, Killian KJ, O’Byrne PM, Raina P, et al. Prevalence and risk factors for refractory and untreated chronic cough in the Canadian Longitudinal Study of Aging. ERJ Open Res. 2026;12(4):01659-2025. doi:10.1183/23120541.01659-2025.
11.
Chamberlain SAF, Garrod R, Douiri A, Masefield S, Powell P, Bücher C, et al. The impact of chronic cough: a cross-sectional European survey. Lung. 2015;193(3):401–408. doi:10.1007/s00408-015-9701-2.
12.
Grabczak EM. Przewlekły kaszel z punktu widzenia lekarza praktyka. Zjazd PTChP; 2016; Wisła.
13.
Kukiełka P, Moliszewska K, Białek-Gosk K, Grabczak EM, Dąbrowska M. Prevalence of refractory and unexplained chronic cough in adults treated in cough centre. ERJ Open Res. 2024;10(5):00254-2024. doi:10.1183/23120541.00254-2024.
14.
Arinze JT, van der Veer T, Bos D, Stricker B, Verhamme KMC, Brusselle G. Epidemiology of unexplained chronic cough in adults: a population-based study. ERJ Open Res. 2023;9(3):00739-2022. doi:10.1183/23120541.00739-2022.
15.
Arinze JT, de Roos EW, Karimi L, Verhamme KMC, Stricker BH, Brusselle GG. Prevalence and incidence of, and risk factors for chronic cough in the adult population: the Rotterdam Study. ERJ Open Res. 2020;6(2):00300-2019. doi:10.1183/23120541.00300-2019.
16.
Arinze JT, Hofman A, de Roos EW, de Ridder MAJ, Verhamme KMC, Stricker B, et al. The interrelationship of chronic cough and depression: a prospective population-based study. ERJ Open Res. 2022;8(2):00069-2022. doi:10.1183/23120541.00069-2022.
17.
Guilleminault L, Li VW, Fonseca E, Martin A, Schelfhout J, Ding H, et al. Prevalence and burden of chronic cough in France. ERJ Open Res. 2024;10(2):00806-2023. doi:10.1183/23120541.00806-2023.
18.
Hull JH, Langerman H, Ul-Haq Z, Kamalati T, Lucas A, Levy ML. Burden and impact of chronic cough in UK primary care: a dataset analysis. BMJ Open. 2021;11(12):e054832. doi:10.1136/bmjopen-2021-054832.
19.
Galgani S, Sawyer C, King J, Dockry R, Wingfield-Digby J, Holt K, et al. Development and validation of a novel questionnaire to describe and assess sensations and triggers associated with refractory and unexplained chronic cough. BMJ Open Respir Res. 2024;11(1):e002430. doi:10.1136/bmjresp-2024-002430.
20.
Wu TY, Taylor JM, Kilfoyle DH, Smith AD, McGuinness BJ, Simpson MP, et al. Autonomic dysfunction is a major feature of cerebellar ataxia, neuropathy, vestibular areflexia ‘CANVAS’ syndrome. Brain. 2014;137(Pt 10):2649–2656. doi:10.1093/brain/awu196.
21.
Szmulewicz DJ, McLean CA, MacDougall HG, Roberts L, Storey E, Halmagyi GM. CANVAS an update: clinical presentation, investigation and management. J Vestib Res. 2014;24(5–6):465–474.
22.
Guilleminault L, Mazzone SB, Chazelas P, Frachet S, Lia AS, Magy L. Cerebellar ataxia, neuropathy and vestibular areflexia syndrome: a neurogenic cough prototype. ERJ Open Res. 2024;10(4):00024-2024. doi:10.1183/23120541.00024-2024.
23.
Cortese A, Simone R, Sullivan R, Vandrovcova J, Tariq H, Yau WY, et al. Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia. Nat Genet. 2019;51(4):649–658. doi:10.1038/s41588-019-0372-4.
24.
Amador R, Goebel R, Noordzij JR, Bhatt NK, Cohen S, Daniels K, et al. A systematic review and meta-analysis of neuromodulators to treat chronic airway hypersensitivity. Am J Otolaryngol. 2023;44(3):103815. doi:10.1016/j.amjoto.2023.103815.